Published in Antimicrob Agents Chemother on February 01, 1988
Fluoroquinolone antimicrobial agents. Clin Microbiol Rev (1989) 6.45
Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxydans by DNA restriction fragment length polymorphism. J Clin Microbiol (1994) 2.60
Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J Clin Microbiol (2001) 1.86
Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol (2001) 1.43
Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods. Antimicrob Agents Chemother (1997) 1.37
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. Antimicrob Agents Chemother (1996) 1.34
Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes. PLoS One (2013) 1.25
First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM. Antimicrob Agents Chemother (2011) 1.14
MexXY multidrug efflux system of Pseudomonas aeruginosa. Front Microbiol (2012) 1.11
Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump. Antimicrob Agents Chemother (2012) 1.04
Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis (1997) 1.04
Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis. Eur J Clin Microbiol Infect Dis (1998) 1.02
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans. Antimicrob Agents Chemother (2008) 1.01
Identification of a carbenicillin-hydrolyzing beta-lactamase in Alcaligenes denitrificans subsp. xylosoxydans. Antimicrob Agents Chemother (1995) 1.01
Alcaligenes xylosoxidans endocarditis of a prosthetic valve and pacemaker in a 62-year-old woman. Tex Heart Inst J (2013) 0.96
Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans. Antimicrob Agents Chemother (2014) 0.88
Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients. PeerJ (2015) 0.77
Environmental Distribution and Drug Susceptibility of Achromobacter Xylosoxidans Isolated from Outdoor and Indoor Environments. Yonago Acta Med (2017) 0.75
A pan-genomic approach to understand the basis of host adaptation in Achromobacter. Genome Biol Evol (2017) 0.75
Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative study. Antimicrob Agents Chemother (1978) 8.08
Strains of Achromobacter xylosoxidans from clinical material. J Clin Pathol (1977) 3.04
Identification of Achromobacter species by cellular fatty acids and by production of keto acids. J Clin Microbiol (1978) 2.90
Cerebral ventriculitis associated with Achromobacter xylosoxidans. J Clin Pathol (1978) 2.86
Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol (1980) 2.43
Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol (1984) 2.24
Achromobacter xylosoxidans isolates in Hawaii. J Clin Microbiol (1978) 2.19
Community-acquired bacteremic Achromobacter xylosoxidans type IIIa pneumonia in a patient with idiopathic IgM deficiency. Am J Clin Pathol (1978) 1.98
Achromobacter species (CDC group Vd): morphological and biochemical characterization. J Clin Microbiol (1979) 1.85
A plasmid-mediated cephalosporinase from Achromobacter species. J Infect Dis (1982) 1.55
Neonatal meningitis caused by Achromobacter xylosoxidans. J Clin Microbiol (1985) 1.42
Achromobacter septicemia-fatalities in prematures. I. Clinical and epidemiological study. Am J Dis Child (1961) 1.35
An outbreak of Achromobacter xylosoxidans related to diagnostic tracer procedures. Am J Epidemiol (1982) 1.14
Infections due to Achromobacter xylosoxidans. Case report and review of the literature. Infection (1987) 1.06
Peritonitis caused by Alcaligenes denitrificans subsp. xylosoxydans: case report and review of the literature. J Clin Microbiol (1986) 0.99
Prosthetic valve endocarditis due to Achromobacter xylosoxidans. Am Heart J (1981) 0.96
Corneal ulcer due to Achromobacter xylosoxidans. Br J Ophthalmol (1984) 0.95
Postoperative infection of an aortic prosthesis with Achromobacter xylosoxidans. West J Med (1982) 0.94
Purification and properties of a beta-lactamase from Alcaligenes dentrificans subsp. xylosoxydans. J Antimicrob Chemother (1985) 0.94
Achromobacter pneumonia. West J Med (1982) 0.82
Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother (1978) 5.42
In vitro protein translocation across the yeast endoplasmic reticulum: ATP-dependent posttranslational translocation of the prepro-alpha-factor. Cell (1986) 4.59
Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods. J Clin Microbiol (1998) 4.07
Targeted selection of recombinant clones through gene dosage effects. Proc Natl Acad Sci U S A (1983) 3.33
Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents. Res Microbiol (1989) 3.29
Evaluation of API Coryne in comparison with conventional methods for identifying coryneform bacteria. J Clin Microbiol (1991) 2.62
Halophilic, lactose-positive Vibrio in a case of fatal septicemia. J Clin Microbiol (1979) 2.45
Restriction endonuclease analysis of Staphylococcus epidermidis DNA may be a useful epidemiological marker. J Clin Microbiol (1988) 2.27
Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol (1991) 2.26
Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol (1984) 2.24
Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria. Antimicrob Agents Chemother (1986) 2.12
Genes required for completion of import of proteins into the endoplasmic reticulum in yeast. J Cell Biol (1984) 2.00
Multicenter evaluation of the updated and extended API (RAPID) Coryne database 2.0. J Clin Microbiol (1997) 1.99
Invertase beta-galactosidase hybrid proteins fail to be transported from the endoplasmic reticulum in Saccharomyces cerevisiae. Mol Cell Biol (1984) 1.91
Detection of beta-glucuronidase in lactose-fermenting members of the family Enterobacteriaceae and its presence in bacterial urine cultures. J Clin Microbiol (1984) 1.78
Legionella taurinensis sp. nov., a new species antigenically similar to Legionella spiritensis. Int J Syst Bacteriol (1999) 1.68
Gas-liquid chromatography as screening test for Clostridium difficile. Lancet (1981) 1.63
Method for differentiating Klebsiella planticola and Klebsiella terrigena from other Klebsiella species. J Clin Microbiol (1994) 1.60
Isolation of Serratia ficaria from human clinical specimens. J Clin Microbiol (1984) 1.55
Nosocomial infection and colonization by Klebsiella trevisanii. J Clin Microbiol (1986) 1.54
Rapid isolation of DNA from Actinomyces. Ann Inst Pasteur Microbiol (1988) 1.52
Difficulties in identifying Klebsiella strains of clinical origin. Zentralbl Bakteriol (1991) 1.51
Klebsiella trevisanii colonisation and septicaemia. Lancet (1984) 1.50
Flavobacterium multivorum septicemia in a hemodialyzed patient. J Clin Microbiol (1984) 1.49
Plesiomonas shigelloides septicemia in a patient with primary hemochromatosis. Clin Infect Dis (1995) 1.48
Small ribonucleoproteins in Schizosaccharomyces pombe and Yarrowia lipolytica homologous to signal recognition particle. Proc Natl Acad Sci U S A (1988) 1.39
Identification of Staphylococcus species by 16S-23S rDNA intergenic spacer PCR analysis. Int J Syst Bacteriol (1998) 1.38
Interaction of mixed-function oxidation with biosynthetic processes. 1. Inhibition of gluconeogenesis by aminopyrine in perfused rat liver. Eur J Biochem (1973) 1.36
Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species. J Clin Microbiol (1996) 1.35
Speed of bactericidal action of penicillin G, ampicillin, and carbenicillin on Bacteroides fragilis. Antimicrob Agents Chemother (1974) 1.31
Postoperative infant septicemia caused by Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2). J Clin Microbiol (1988) 1.29
Evaluation of the new Vitek 2 GN card for the identification of gram-negative bacilli frequently encountered in clinical laboratories. Eur J Clin Microbiol Infect Dis (2005) 1.26
Spin wave diffraction and perfect imaging of a grating. Phys Rev Lett (2012) 1.25
Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin. Am J Gastroenterol (1988) 1.24
Optical Properties of GaAs Quantum Dots Fabricated by Filling of Self-Assembled Nanoholes. Nanoscale Res Lett (2009) 1.23
Reliability of Pseudomonas aeruginosa semi-automated rep-PCR genotyping in various epidemiological situations. Eur J Clin Microbiol Infect Dis (2009) 1.23
Septicemia caused by Sphingobacterium multivorum. J Clin Microbiol (1987) 1.22
Campylobacter jejuni post-transfusional septicaemia. Lancet (1979) 1.20
Stomatitis with septicemia due to Moraxella osloensis. J Pediatr (1974) 1.20
Effect of antibiotics carry-over on bacterial counting by 'spiral plating'. J Antimicrob Chemother (1988) 1.19
Isolation of penicillin and streptomycin resistant strains of Moraxella osloensis. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.16
Rapid diagnosis of Mycobacterium tuberculosis infections by an ELISA-like detection of polymerase chain reaction products. Mol Cell Probes (1995) 1.16
Chemotaxonomy and molecular taxonomy of some coryneform clinical isolates. Zentralbl Bakteriol (1993) 1.15
Comparative inhibitory activity of BL-S640 and two other cephalosporins. J Antibiot (Tokyo) (1975) 1.11
Isolation of Mobiluncus in four cases of extragenital infections in adult women. Eur J Clin Microbiol (1984) 1.10
Ribotyping: a tool for taxonomy and identification of the Nocardia asteroides complex species. J Clin Microbiol (1996) 1.10
Identification of Turicella otitidis isolated from a patient with otorrhea associated with surgery: differentiation from Corynebacterium afermentans and Corynebacterium auris. J Clin Microbiol (1996) 1.10
A sentinel network of microbiological laboratories as a tool for surveillance of infectious diseases in Belgium. Epidemiol Infect (1991) 1.08
In vitro protein translocation across microsomal membranes of Saccharomyces cerevisiae. Methods Enzymol (1991) 1.08
Evaluation of API NH, a new 2-hour system for identification of Neisseria and Haemophilus species and Moraxella catarrhalis in a routine clinical laboratory. J Clin Microbiol (1994) 1.06
CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation. Gut (2005) 1.06
Septicemia caused by Agrobacterium sp. J Clin Microbiol (1985) 1.06
Cross-reactivity of environmental bacteria with fluorescent-antibody conjugates for Legionella pneumophila. Eur J Clin Microbiol (1984) 1.06
Isolation of Bacteroides corrodens and Eikenella corrodens from human clinical specimens. Comparative study of incidence and methods of identification. Infection (1977) 1.06
[Effects of sodium chloride on the antistaphylococcal action of gentamicin]. Pathol Biol (Paris) (1972) 1.06
Antagonism limit of penicillin G and chloramphenicol against Neisseria meningitidis. Arzneimittelforschung (1971) 1.06
Activities of amoxicillin and clavulanic acid combinations against urinary tract infections. Antimicrob Agents Chemother (1982) 1.05
Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clin Infect Dis (1995) 1.05
Isolation of Escherichia fergosonii from a patient with septicemia in France. Eur J Clin Microbiol (1987) 1.05
Two resistance phenotypes to beta-lactams of Alcaligenes denitrificans subsp. xylosoxydans in relation to beta-lactamase types. J Antimicrob Chemother (1990) 1.05
Comparative in vitro acitvity of chloramphenicol and thiamphenicol on common aerobic and anaerobic gram-negative bacilli(Salmonella and Shigella excluded). Chemotherapy (1975) 1.04
Staphylococcus fleurettii sp. nov., isolated from goat's milk cheeses. Int J Syst Evol Microbiol (2000) 1.04
Thermal conductance of ballistic point contacts. Phys Rev Lett (2012) 1.04
Pseudomonas paucimobilis peritonitis in patients treated by peritoneal dialysis. J Clin Microbiol (1984) 1.04
Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis (1992) 1.03
In-vitro activity of new cephalosporin (HR 756) and cefazolin. Lancet (1978) 1.03
Growth curve patterns and bacterial morphology of Escherichia coli subjected to different temocillin (BRL 17421) concentrations. J Antimicrob Chemother (1982) 1.03
In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther (2005) 1.02
Evaluation of CPS ID2 medium for detection of urinary tract bacterial isolates in specimens from a rehabilitation center. J Clin Microbiol (1995) 1.02
Corynebacterium singulare sp. nov., a new species for urease-positive strains related to Corynebacterium minutissimum. Int J Syst Bacteriol (1997) 1.02
Pseudomonas stutzeri pneumonia and septicemia in a patient with multiple myeloma. J Clin Microbiol (1987) 1.02
Persistent bacteremia due to Brevibacterium species in an immunocompromised patient. Clin Infect Dis (1994) 1.02
[Relationship between the level of minimal inhibitory concentrations of five antiseptics and the presence of qacA gene in Staphylococcus aureus]. Pathol Biol (Paris) (1994) 1.01
Molecular epidemiology of Staphylococcus haemolyticus strains isolated in an Albanian hospital. J Clin Microbiol (1991) 1.01
Growth curves, microscopic morphology, and subcultures of beta-lactamase-positive and -negative Haemophilus influenzae under the influence of ampicillin and cefamandole. Antimicrob Agents Chemother (1979) 1.01
Qualitative study of paradoxical zone phenomenon of penicillins against 17 bacterial species of clinical importance. Chemotherapy (1978) 1.01
Severe human infections caused by Vibrio metschnikovii. J Clin Microbiol (1993) 1.00
Anaerobic bacteria isolated from decubitus ulcers. Infection (1973) 0.98
Activity of ten cephalosporins on biomass of methicillin-susceptible and -resistant Staphylococcus aureus. Antimicrob Agents Chemother (1980) 0.98
Instability of characteristics amongst coagulase-negative staphylococci causing endocarditis. J Med Microbiol (1990) 0.98
Differentiation of Corynebacterium amycolatum, C. minutissimum, and C. striatum by carbon substrate assimilation tests. J Clin Microbiol (1998) 0.97
Distribution of Staphylococcus sciuri subspecies among human clinical specimens, and profile of antibiotic resistance. Res Microbiol (1999) 0.97
Postoperative tetanus. Lancet (1984) 0.97
Neutron spectrometry in mixed fields: proportional counter spectrometers. Radiat Prot Dosimetry (2003) 0.96
Effect of heparin on gentamicin concentration in blood. Clin Chim Acta (1972) 0.96
Using an efficient biofilm detaching agent: an essential step for the improvement of endoscope reprocessing protocols. J Hosp Infect (2006) 0.96
The use of gene-fusions to determine membrane protein topology in Saccharomyces cerevisiae. J Cell Sci Suppl (1989) 0.95
Prevalence and severity of urinary incontinence in ambulatory adults: an UPRNet study. J Fam Pract (1993) 0.94
Clinical impact of rapid oxacillin susceptibility testing using a PCR assay in Staphylococcus aureus bactaeremia. J Infect (1999) 0.94
Taxonomy of Acinetobacter: the usefulness of beta-D-xyloside xylohydrolase for strain differentiation. J Clin Pathol (1977) 0.93
Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas. Chest (1988) 0.93
Capsular types and antibiotic sensitivity of pneumococci isolated from patients with serious infections in Belgium 1980 to 1988. Eur J Clin Microbiol Infect Dis (1990) 0.92